Biomedical Engineering Center, Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Cancer Res. 2011 Dec 15;71(24):7339-44. doi: 10.1158/0008-5472.CAN-11-1718. Epub 2011 Dec 5.
Although the roles of endothelial cells in cancer have primarily been considered to be related to tumor perfusion, the emerging appreciation of "angiocrine" regulation adds stromal regulatory capabilities to the expanding list of endothelial functions in tumors. We posit that an understanding of the state-dependent paracrine regulatory paradigms established in vascular disease and repair will be critical for a deep understanding of tumor biology, as endothelial cells regulate diverse processes in all vascularized tissues. Here, we outline the historical developments that led to the appreciation of the paracrine regulatory functions of endothelial cells, summarize classical views of blood vessels and stroma in cancer, and attempt to merge these ideas to include the stromal regulatory endothelial cell as a critical regulator of cancer. The notion of the endothelial cell as a biochemical regulator of cancer state in constant dynamic balance with its tumor could impact diagnosis, prognosis, and treatment of cancer. Such concepts might well explain the mixed results from antiangiogenic cancer therapeutics and how certain drugs that improve vascular health correlate with improved cancer prognosis.
虽然内皮细胞在癌症中的作用主要被认为与肿瘤灌注有关,但对“血管分泌”调节的新认识增加了基质的调节能力,使内皮细胞在肿瘤中的功能不断扩展。我们假设,对血管疾病和修复中建立的状态依赖性旁分泌调节模式的理解,对于深入了解肿瘤生物学至关重要,因为内皮细胞调节所有血管化组织中的多种过程。在这里,我们概述了导致对内皮细胞旁分泌调节功能的认识的历史发展,总结了癌症中血管和基质的经典观点,并试图将这些观点结合起来,将作为肿瘤关键调节者的基质调节内皮细胞包括在内。内皮细胞作为癌症状态的生化调节剂的概念与肿瘤处于不断的动态平衡中,这可能会影响癌症的诊断、预后和治疗。这些概念很可能解释了抗血管生成癌症治疗的结果为何不一致,以及某些改善血管健康的药物为何与改善癌症预后相关。